loader2
Partner With Us NRI

Themis Medicare Ltd share Price Today

Company details

214.20
220.55
131.61
263.85
6M Return 19.38%
1Y Return 72.19%
Mkt Cap.(Cr) 1,984.12
Volume 45,661
Div Yield 0.23%
OI
-
OI Chg %
-
Volume 45,661

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Themis Medicare Ltd shares SWOT Analysis

Strengths (3)

  • Company with Low Debt
  • Book Value per share Improving for last 2 years
  • Company with decreasing Promoter pledge

Weakness (7)

  • MACD Crossover Below Signal Line
  • Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
  • Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)

Opportunity (0)

Data not found

Threats (2)

  • High PE (PE > 40)
  • RSI indicating price weakness

Resistance and support

R1 219.4
R2 223.1
R3 225.7
Pivot

216.78

S1 213.0
S2 210.4
S3 206.7
EMA SMA
224.3
223.4
212.6
191.8
221.0
228.9
212.3
186.0
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
TEJAS TRADEFIN LLP Bulk Purchase 2021-06-02 735.76 72009 NSE
ANUJ ANANTRAI SHETH Bulk Purchase 2013-03-12 60.25 112500 BSE
GAGANDEEP CREDIT CAPITAL PRIVATE LIMITED Bulk Sell 2013-03-12 60.25 112500 BSE
Name Category Shares
Dinesh Shantilal Patel PROMOTER 9.48%
Jayshree D Patel PROMOTER 7.26%
Sachin Dinesh Patel PROMOTER 5.99%
Reena S Patel PROMOTER 4.04%
Anay Rupen Choksi PROMOTER 1.28%
Nysha Rupen Choksi PROMOTER 1.28%
Dinesh S Patel HUF PROMOTER 1.07%
Shantilal Dahyabhai Patel HUF PROMOTER 0.61%
Vividhmargi Investments Pvt PROMOTER 15.79%
Gedeon Richter Investment Management Ltd. PROMOTER 9.61%
Vividh Distributors Private Ltd. PROMOTER 7.78%
Themis Distributors Private Ltd. PROMOTER 2.98%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Themis Medicare Ltd Stocks COMPARISON

Financials( in Cr) Themis Medicare Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Divis Laboratories Ltd
Price 215.60 1,540.00 1,396.80 6,083.85 3,779.70
% Change -1.15 -3.99 -1.84 -1.20 1.09
Mcap Cr 1,984.12 369,497.59 112,770.65 101,484.09 100,339.32
Revenue TTM Cr 354.32 43,885.68 15,790.60 24,669.70 7,767.51
Net Profit TTM Cr 56.90 8,560.84 2,513.47 4,507.30 1,823.38
PE TTM 43.85 39.38 28.51 19.41 72.54
1 Year Return 72.19 52.69 54.88 27.82 29.90
ROCE 22.45 16.79 14.76 25.99 19.30
ROE 20.36 16.46 10.66 21.21 14.89
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 339.44 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 20,771.53 7,735.64
LAST 3M 82,392.14 52,275.07
LAST 6M 132,482.07 84,624.18
LAST 12M 206,189.80 211,987.34

Themis Medicare Ltd Information

Stock PE (TTM)
43.85
Promoter Holding
67.16%
Book Value
35.8944
ROCE
22.45%
ROE
20.36%
Description
  • Incorporated in 1969, Themis Medicare Ltd., formerly known as Themis Chemicals (TCL) was originally promoted by Chemosyn and Medimpex but was taken over by a group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April 93. In Mar.`95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital. Total cost of the project was estimated at Rs 17.64 cr. TCL manufactures and sells synthetic bulk drugs and formulations. It operates in the therapeutic segments of anti-tuberculosis, cerebroactivators, bronchodilators, anti-asthmatic, anaesthetic and other segments. Anti-tuberculosis bulk drugs and formulations account for 60% of its turnover and the company is rated fourth in terms of turnover in this segment. TCL has also started manufacturing and exporting fumagillin, an anti-bacterial drug, for veterinary use for which it has a confirmed buy-back arrangement with Chinoin, Hungary. The company with the help of M/s Pharmograd,Moscow a manufacturing unit, is planning to market its Anti-T.B.formulation products through the collborators throughout the Russian Federation for trade,tenders and govt.supplies.

Registered Address

Plot No 69 A GIDC Indl Estate, Vapi, Valsad, Gujarat, 396195

Tel : 91-260-2421675
Email : sangameshwar.iyer:themismedicare.com; cfoassist:th
Website : http://www.themismedicare.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 530199
NSE Code : THEMISMED
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE083B01024

FAQ’s on Themis Medicare Ltd Shares

You can buy Themis Medicare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Themis Medicare Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 12, 2024 03:41 PM the closing price of Themis Medicare Ltd was ₹ 215.60.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 12, 2024 03:41 PM, the market cap of Themis Medicare Ltd stood at ₹ 1,984.12.

The latest PE ratio of Themis Medicare Ltd as of Apr 12, 2024 03:41 PM is 43.85

The latest PB ratio of Themis Medicare Ltd as of Apr 12, 2024 03:41 PM is 0.17

The 52-week high of Themis Medicare Ltd share price is ₹ 263.85 while the 52-week low is ₹ 131.61

Download Our

Download App
market app